Replimune Group, Inc. (REPL)
5.845
-1.96
(-25.06%)
USD |
NASDAQ |
Apr 08, 16:00
5.86
+0.02
(+0.26%)
After-Hours: 16:03
Replimune Group Cash from Investing (TTM) : 216.64M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | -34.32M |
| Phathom Pharmaceuticals, Inc. | -0.229M |
| REGENXBIO, Inc. | -15.87M |
| Corcept Therapeutics, Inc. | 69.76M |
| Catalyst Pharmaceuticals, Inc. | -0.058M |